386529004: Aspirin + caffeine + orphenadrine citrate tablet (product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1460708016 Aspirin + caffeine + orphenadrine citrate tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1480674017 Aspirin + caffeine + orphenadrine citrate tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4232951000005116 acetylsalicylsyre + caffein + orphenadrincitrat tablet da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
acetylsalicylsyre + caffein + orphenadrincitrat tablet	Is a	kombinationspræparat med acetylsalicylsyre	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat tablet	Is a	Product containing caffeine in oral dose form (medicinal product form)	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Caffeine	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Bronchodilator (substance)	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Stimulant (substance)	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Aspirin (substance)	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Xanthine	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat tablet	Is a	acetylsalicylsyre + caffein + orphenadrincitrat	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Orphenadrine (substance)	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Phosphodiesterase inhibitor	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat tablet	Has manufactured dose form	A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition.	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Orphenadrine citrate (substance)	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Xanthine	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat tablet	Has manufactured dose form	Oral tablet	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	Is a	False	acetylsalicylsyre + caffein + orphenadrincitrat tablet	Inferred relationship	Some
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	Is a	False	acetylsalicylsyre + caffein + orphenadrincitrat tablet	Inferred relationship	Some
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	Is a	False	acetylsalicylsyre + caffein + orphenadrincitrat tablet	Inferred relationship	Some
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	Is a	False	acetylsalicylsyre + caffein + orphenadrincitrat tablet	Inferred relationship	Some

Reference Sets

Concept inactivation indicator reference set

Description inactivation indicator reference set

GB English

US English

POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1460708016	Aspirin + caffeine + orphenadrine citrate tablet (product)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1480674017	Aspirin + caffeine + orphenadrine citrate tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4232951000005116	acetylsalicylsyre + caffein + orphenadrincitrat tablet	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)